A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcinoma

被引:17
作者
Zahoor, Haris [1 ]
Luketich, James D. [2 ]
Levy, Ryan M. [2 ]
Awais, Omar [2 ]
Winger, Daniel G. [3 ]
Gibson, Michael K. [4 ]
Nason, Katie S. [2 ]
机构
[1] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA USA
[3] Univ Pittsburgh, Translat Sci Inst, Pittsburgh, PA USA
[4] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
关键词
RANDOMIZED CONTROLLED-TRIALS; DISEASE-FREE SURVIVAL; PREOPERATIVE CHEMORADIATION; ENDOSCOPIC ULTRASOUND; COMPLETE RESPONSE; SURGERY; CANCER; CHEMOTHERAPY; CHEMORADIOTHERAPY; OUTCOMES;
D O I
10.1016/j.jtcvs.2014.10.044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Prognosis for patients with locally advanced esophagogastric adenocarcinoma (EAC) is poor with surgery alone, and adjuvant therapy after open esophagectomy is frequently not tolerated. After minimally invasive esophagectomy (MIE); however, earlier return to normal function may render patients better able to receive adjuvant therapy. We examined whether primary MIE followed by adjuvant chemotherapy influenced survival compared with propensity-matched patients treated with neoadjuvant therapy. Methods: Patients with stage II or higher EAC treated with MIE (N = 375) were identified. Using 30 pretreatment covariates, propensity for assignment to either neoadjuvant followed by MIE (n = 183; 54%) or MIE as primary therapy (n = 156; 46%) was calculated, generating 97 closely matched pairs. Hazard ratios were adjusted for age, sex, body mass index, smoking, comorbidity, and final pathologic stage. Results: In propensity-matched pairs, adjusted hazard ratio for death did not differ significantly for primary MIE compared with neoadjuvant (hazard ratio, 0.83; 95% confidence interval, 0.60-1.16). Recurrence patterns were similar between groups and 65% of patients with IIb or greater pathologic stage received adjuvant therapy. Clinical staging was inaccurate in 37 out of 105 patients (35%) who underwent primary MIE (n = 18 upstaged and n = 19 downstaged). Conclusions: Primary MIE followed by adjuvant chemotherapy guided by pathologic findings did not negatively influence survival and allowed for accurate staging compared with clinical staging. Our data suggest that primary MIE in patients with resectable EAC may be a reasonable approach, improving stage-based prognostication and potentially minimizing overtreatment in patients with early stage disease through accurate stage assignments. A randomized controlled trial testing this hypothesis is needed.
引用
收藏
页码:538 / 547
页数:10
相关论文
共 48 条
[1]   Recurrence after Esophagectomy for Adenocarcinoma: Defining Optimal Follow-Up Intervals and Testing [J].
Abate, Emmanuele ;
DeMeester, Steven R. ;
Zehetner, Joerg ;
Oezcelik, Arzu ;
Ayazi, Shahin ;
Costales, Jesse ;
Banki, Farzaneh ;
Lipham, John C. ;
Hagen, Jeffrey A. ;
DeMeester, Tom R. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2010, 210 (04) :428-435
[2]   Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux [J].
Agarwal, B ;
Swisher, SG ;
Ajani, J ;
Kelly, K ;
Komaki, RR ;
Abu-Hamda, E ;
Correa, AM ;
Roth, JA .
ANNALS OF THORACIC SURGERY, 2005, 79 (05) :1716-1723
[3]   Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study - JCOG9204 [J].
Ando, N ;
Iizuka, T ;
Ide, H ;
Ishida, K ;
Shinoda, M ;
Nishimaki, T ;
Takiyama, W ;
Watanabe, H ;
Isono, K ;
Aoyama, N ;
Makuuchi, H ;
Tanaka, O ;
Yamana, H ;
Ikeuchi, S ;
Kabuto, T ;
Nagai, K ;
Shimoda, Y ;
Kinjo, Y .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4592-4596
[4]  
Bang YJ, 2010, LANCET, V376, P1302
[5]   Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies [J].
Bergeron, Edward J. ;
Lin, Jules ;
Chang, Andrew C. ;
Orringer, Mark B. ;
Reddy, Rishindra M. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 147 (02) :765-771
[6]  
Bergeron EJ, 2014, J THORAC CARDIOVASC, V147, P71
[7]   Traditional invasive vs. minimally invasive esophagectomy: a multi-center, randomized trial (TIME-trial) [J].
Biere, Surya S. A. Y. ;
Maas, Kirsten W. ;
Bonavina, Luigi ;
Roig Garcia, Josep ;
Henegouwen, Mark I. van Berge ;
Rosman, Camiel ;
Sosef, Meindert N. ;
de lange, Elly S. M. ;
Bonjer, H. Jaap ;
Cuesta, Miguel A. ;
van der Peet, Donald L. .
BMC SURGERY, 2011, 11
[8]   A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].
CHARLSON, ME ;
POMPEI, P ;
ALES, KL ;
MACKENZIE, CR .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383
[9]   Comparison of endoscopic ultrasonography (EUS), positron emission tomography (PET), and computed tomography (CT) in the preoperative locoregional staging of resectable esophageal cancer [J].
Choi, Jeongmin ;
Kim, Sang Gyun ;
Kim, Joo Sung ;
Jung, Hyun Chae ;
Song, In Sung .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2010, 24 (06) :1380-1386
[10]   Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer [J].
Cunningham, David ;
Allum, William H. ;
Stenning, Sally P. ;
Thompson, Jeremy N. ;
Van de Velde, Cornelis J. H. ;
Nicolson, Marianne ;
Scarffe, J. Howard ;
Lofts, Fiona J. ;
Falk, Stephen J. ;
Iveson, Timothy J. ;
Smith, David B. ;
Langley, Ruth E. ;
Verma, Monica ;
Weeden, Simon ;
Chua, Yu Jo .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (01) :11-20